Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma

Sung Wei Lee, Tzu Ju Chen, Li Ching Lin, Chien Feng Li, Li Tzong Chen, Chung-Hsi Hsing, Han Ping Hsu, Chia Jung Tsai, Hsuan Ying Huang, Yow Ling Shiue

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Data mining on public domain identified that thymidylate synthetase (TYMS) and dihydrofolate reductase (DHFR) transcripts were significantly higher expressed in nasopharyngeal carcinoma (NPC). In the folate pathway, TYMS catalyzes the methylation of deoxyuridylate to deoxythymidylate using 5,10-methylenetetrahydrofolate [5,10-CH2=THF, derived from tetrahydrofolate (THF)], as a cofactor. This function maintains the thymidine-5-prime monophosphate pool critical for DNA replication and repair and, THF is generated from dihydrofolate (DHF) through the activity of DHFR. Immunoexpression of TYMS and DHFR were retrospectively assessed in biopsies of 124 consecutive NPC patients without initial distant metastasis and treated with consistent guidelines. The outcome was correlated with clinicopathological features and patient survivals. Results indicated that high TYMS (50%) expressions were correlated with primary tumor (p=0.008) and AJCC stage (p=0.006), and high DHFR (50%) expression were correlated with nodal status (p=0.039) and AJCC stage (p=0.029) (7th American Joint Committee on Cancer), respectively. In multivariate analyses, high TYMS expression emerged as an independent prognosticator for worse disease-specific survival (p

Original languageEnglish
Pages (from-to)83-90
Number of pages8
JournalExperimental and Molecular Pathology
Volume95
Issue number1
DOIs
Publication statusPublished - Aug 2013
Externally publishedYes

Fingerprint

Thymidylate Synthase
Tetrahydrofolate Dehydrogenase
Thymidine Monophosphate
Methylation
Data Mining
Survival
Biopsy
Public Sector
DNA Replication
Folic Acid
DNA Repair
Thymidine
Data mining
Tumors
Neoplasms
Repair
Multivariate Analysis
Nasopharyngeal carcinoma
Guidelines
Neoplasm Metastasis

Keywords

  • Nasopharyngeal carcinoma
  • Survival
  • Thymidylate synthetase
  • TYMS

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Pathology and Forensic Medicine

Cite this

Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma. / Lee, Sung Wei; Chen, Tzu Ju; Lin, Li Ching; Li, Chien Feng; Chen, Li Tzong; Hsing, Chung-Hsi; Hsu, Han Ping; Tsai, Chia Jung; Huang, Hsuan Ying; Shiue, Yow Ling.

In: Experimental and Molecular Pathology, Vol. 95, No. 1, 08.2013, p. 83-90.

Research output: Contribution to journalArticle

Lee, SW, Chen, TJ, Lin, LC, Li, CF, Chen, LT, Hsing, C-H, Hsu, HP, Tsai, CJ, Huang, HY & Shiue, YL 2013, 'Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma', Experimental and Molecular Pathology, vol. 95, no. 1, pp. 83-90. https://doi.org/10.1016/j.yexmp.2013.05.006
Lee, Sung Wei ; Chen, Tzu Ju ; Lin, Li Ching ; Li, Chien Feng ; Chen, Li Tzong ; Hsing, Chung-Hsi ; Hsu, Han Ping ; Tsai, Chia Jung ; Huang, Hsuan Ying ; Shiue, Yow Ling. / Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma. In: Experimental and Molecular Pathology. 2013 ; Vol. 95, No. 1. pp. 83-90.
@article{a73b3977595b4de58ba742d459fce8b7,
title = "Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma",
abstract = "Data mining on public domain identified that thymidylate synthetase (TYMS) and dihydrofolate reductase (DHFR) transcripts were significantly higher expressed in nasopharyngeal carcinoma (NPC). In the folate pathway, TYMS catalyzes the methylation of deoxyuridylate to deoxythymidylate using 5,10-methylenetetrahydrofolate [5,10-CH2=THF, derived from tetrahydrofolate (THF)], as a cofactor. This function maintains the thymidine-5-prime monophosphate pool critical for DNA replication and repair and, THF is generated from dihydrofolate (DHF) through the activity of DHFR. Immunoexpression of TYMS and DHFR were retrospectively assessed in biopsies of 124 consecutive NPC patients without initial distant metastasis and treated with consistent guidelines. The outcome was correlated with clinicopathological features and patient survivals. Results indicated that high TYMS (50{\%}) expressions were correlated with primary tumor (p=0.008) and AJCC stage (p=0.006), and high DHFR (50{\%}) expression were correlated with nodal status (p=0.039) and AJCC stage (p=0.029) (7th American Joint Committee on Cancer), respectively. In multivariate analyses, high TYMS expression emerged as an independent prognosticator for worse disease-specific survival (p",
keywords = "Nasopharyngeal carcinoma, Survival, Thymidylate synthetase, TYMS",
author = "Lee, {Sung Wei} and Chen, {Tzu Ju} and Lin, {Li Ching} and Li, {Chien Feng} and Chen, {Li Tzong} and Chung-Hsi Hsing and Hsu, {Han Ping} and Tsai, {Chia Jung} and Huang, {Hsuan Ying} and Shiue, {Yow Ling}",
year = "2013",
month = "8",
doi = "10.1016/j.yexmp.2013.05.006",
language = "English",
volume = "95",
pages = "83--90",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma

AU - Lee, Sung Wei

AU - Chen, Tzu Ju

AU - Lin, Li Ching

AU - Li, Chien Feng

AU - Chen, Li Tzong

AU - Hsing, Chung-Hsi

AU - Hsu, Han Ping

AU - Tsai, Chia Jung

AU - Huang, Hsuan Ying

AU - Shiue, Yow Ling

PY - 2013/8

Y1 - 2013/8

N2 - Data mining on public domain identified that thymidylate synthetase (TYMS) and dihydrofolate reductase (DHFR) transcripts were significantly higher expressed in nasopharyngeal carcinoma (NPC). In the folate pathway, TYMS catalyzes the methylation of deoxyuridylate to deoxythymidylate using 5,10-methylenetetrahydrofolate [5,10-CH2=THF, derived from tetrahydrofolate (THF)], as a cofactor. This function maintains the thymidine-5-prime monophosphate pool critical for DNA replication and repair and, THF is generated from dihydrofolate (DHF) through the activity of DHFR. Immunoexpression of TYMS and DHFR were retrospectively assessed in biopsies of 124 consecutive NPC patients without initial distant metastasis and treated with consistent guidelines. The outcome was correlated with clinicopathological features and patient survivals. Results indicated that high TYMS (50%) expressions were correlated with primary tumor (p=0.008) and AJCC stage (p=0.006), and high DHFR (50%) expression were correlated with nodal status (p=0.039) and AJCC stage (p=0.029) (7th American Joint Committee on Cancer), respectively. In multivariate analyses, high TYMS expression emerged as an independent prognosticator for worse disease-specific survival (p

AB - Data mining on public domain identified that thymidylate synthetase (TYMS) and dihydrofolate reductase (DHFR) transcripts were significantly higher expressed in nasopharyngeal carcinoma (NPC). In the folate pathway, TYMS catalyzes the methylation of deoxyuridylate to deoxythymidylate using 5,10-methylenetetrahydrofolate [5,10-CH2=THF, derived from tetrahydrofolate (THF)], as a cofactor. This function maintains the thymidine-5-prime monophosphate pool critical for DNA replication and repair and, THF is generated from dihydrofolate (DHF) through the activity of DHFR. Immunoexpression of TYMS and DHFR were retrospectively assessed in biopsies of 124 consecutive NPC patients without initial distant metastasis and treated with consistent guidelines. The outcome was correlated with clinicopathological features and patient survivals. Results indicated that high TYMS (50%) expressions were correlated with primary tumor (p=0.008) and AJCC stage (p=0.006), and high DHFR (50%) expression were correlated with nodal status (p=0.039) and AJCC stage (p=0.029) (7th American Joint Committee on Cancer), respectively. In multivariate analyses, high TYMS expression emerged as an independent prognosticator for worse disease-specific survival (p

KW - Nasopharyngeal carcinoma

KW - Survival

KW - Thymidylate synthetase

KW - TYMS

UR - http://www.scopus.com/inward/record.url?scp=84879588410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879588410&partnerID=8YFLogxK

U2 - 10.1016/j.yexmp.2013.05.006

DO - 10.1016/j.yexmp.2013.05.006

M3 - Article

VL - 95

SP - 83

EP - 90

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

SN - 0014-4800

IS - 1

ER -